Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid

Abdullah Balkhair*, Zakariya Al Muharrmi, Laila Darwish, Hatem Farhan, Mansour Sallam

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

We report a case of infective endocarditis due to vancomycin-intermediate Staphylococcus aureus (VISA). This was treated with a combination of intravenous linezolid and fusidic acid. Cure was achieved without surgical intervention.

Original languageEnglish
Pages (from-to)e227-e229
JournalInternational Journal of Infectious Diseases
Volume14
Issue numberSUPPL. 3
DOIs
Publication statusPublished - Sept 2010

Keywords

  • Endocarditis
  • Linezolid
  • MRSA
  • Staphylococcus aureus
  • VISA

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid'. Together they form a unique fingerprint.

Cite this